Skip to content
The Nexus
DossierENTITY

mRNA-1083

Coverage of mRNA-1083 in the Nexus archive.

Earliest in view: Apr 24 · 21:11 UTCMost recent: Apr 24 · 21:11 UTC
Co-mentioned in this coverage
Modernaorganization1European Commissionorganization1mCOMBRIAXtopic1Stéphane Bancelperson1European Medicines Agencyorganization1flutopic1COVID-19topic1
Recent coverage
  • HEALTHApr 24 · 21:11 UTCARS TECHNICA
    Europe—not US—first to authorize Moderna's combo mRNA flu-COVID vaccine

    Moderna's mRNA-based combination vaccine against flu and COVID-19, mCOMBRIAX (mRNA-1083), has been authorized in Europe by the European Commission, making it the first such combo vaccine. The US, where it was developed, has not yet approved it. The vaccine aims to simplify immunization for high-risk adults and strengthen healthcare systems.

mRNA-1083 · Dossier · The Nexus